Summary
- Current Price
- As of today, ELVN price is $43.83, down -3.29% on
- Current Price All-Time High
- ELVN price is currently -30.11% below its historical high of $62.71 set on
- Market Cap
- ELVN current market cap is $3B, up +221.28% over the past 365 days
- PE Ratio
- ELVN PE ratio is unknown
- Revenue
- ELVN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ELVN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Enliven Therapeutics, Inc. |
| Ticker | NASDAQ: ELVN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | enliventherapeutics.com |
| Employees | 65 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $43.83 | |
| Price, 1D Change | -3.29% | |
| $3B | ||
| - | ||
| - | ||
| 1.38 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.83 | ||
| EPS, 1Y Change | +3.24% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | IMRA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.83 | ||
| EPS Estimate | N/A | -$1.94 |
| EPS Est. Change | N/A | -6.01% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $43.83 | |
| Price Target | - | $52.00 |
| Price Tgt. Change | - | +18.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.59 | -$1.89 | -18.94% | |
| -$1.80 | -$1.83 | -1.67% | |
| -$1.94 | N/A | -6.01% | |
| -$2.54 | N/A | -38.80% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $10.00K | $0.00 | -100.00% | |
| - | N/A | - | |
| $10.00K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $43.83 | |
| $23.27 | ||
| SMA 200 vs Price | -46.91% | |
| $31.54 | ||
| SMA 50 vs Price | -28.04% | |
| 1.38 | ||
| $2.52 | ||
| 70.17 | ||
| 84.35% | ||
| 84.82% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.83 | ||
| -$263.00K | ||
| - | ||
| -$119.66M | ||
| - | ||
| -$103.69M | ||
| - | ||
| -$119.40M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 28.66 | ||
| 28.66 | ||
| - | ||
| - | ||
| 92.90 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.66 | ||
| -17.92 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $459.60M | ||
| $462.62M | ||
| $476.28M | ||
| $474.88M | ||
| $16.68M | ||
| $16.57M | ||
| $399.00K | ||
| $399.00K | ||
| $2.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $103.69M | ||
| $119.40M | ||
| $263.00K | ||
| $0.00 | ||
| $263.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$70.30M | ||
| -$173.84M | ||
| $218.87M | ||
| $158.00K | ||
| -$70.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | ||
| Baird | → | |
| Jones Trading | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | ||
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with ELVN
FAQ
What is the ticker symbol for Enliven Therapeutics, Inc.?
The ticker symbol for Enliven Therapeutics, Inc. is NASDAQ:ELVN
Does Enliven Therapeutics, Inc. pay dividends?
No, Enliven Therapeutics, Inc. does not pay dividends
What sector is Enliven Therapeutics, Inc. in?
Enliven Therapeutics, Inc. is in the Healthcare sector
What industry is Enliven Therapeutics, Inc. in?
Enliven Therapeutics, Inc. is in the Biotechnology industry
What country is Enliven Therapeutics, Inc. based in?
Enliven Therapeutics, Inc. is headquartered in United States
When did Enliven Therapeutics, Inc. go public?
Enliven Therapeutics, Inc. initial public offering (IPO) was on March 12, 2020
Is Enliven Therapeutics, Inc. in the S&P 500?
No, Enliven Therapeutics, Inc. is not included in the S&P 500 index
Is Enliven Therapeutics, Inc. in the NASDAQ 100?
No, Enliven Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Enliven Therapeutics, Inc. in the Dow Jones?
No, Enliven Therapeutics, Inc. is not included in the Dow Jones index
When was Enliven Therapeutics, Inc. last earnings report?
Enliven Therapeutics, Inc.'s most recent earnings report was on March 3, 2026
When does Enliven Therapeutics, Inc. report earnings?
The next expected earnings date for Enliven Therapeutics, Inc. is May 13, 2026
Data Sources & References
- ELVN Official Website www.enliventherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1672619/000119312526088232/0001193125-26-088232-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1672619/000119312526088232/0001193125-26-088232-index.htm
- ELVN Profile on Yahoo Finance finance.yahoo.com/quote/ELVN
- ELVN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elvn